LEDERMAN SETH
SEC insider (Form 3/4/5 filer). CIK 0001563420. Chief Executive Officer at Tonix Pharmaceuticals Holding Corp. (TNXP). 11 reported Form 4/5 transactions since Sep 2024; latest on Jun 9, 2026. Located in BERKELEY HEIGHTS, NJ.
Companies LEDERMAN SETH has filed insider reports for
- Tonix Pharmaceuticals Holding Corp. (TNXP): Director, Officer, Chief Executive Officer
LEDERMAN SETH
CIK: 0001563420
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Tonix Pharmaceuticals Holding Corp.
Discretionary Trading P&L
Holdings
Transaction History (11 total)
- Jun 9, 2026TNXP
Tonix Pharmaceuticals Holding Corp.
PurchaseDirect5K shares at avg. $11.79$59K - Mar 31, 2026TNXP
Tonix Pharmaceuticals Holding Corp.
PurchaseIndirect5K shares at avg. $12.62$63K - Mar 18, 2026TNXP
Tonix Pharmaceuticals Holding Corp.
PurchaseIndirect15K shares at avg. $14.89$223K - Feb 24, 2026TNXP
Tonix Pharmaceuticals Holding Corp.
AwardDirectStock Option
134.5K shares- - Feb 24, 2026TNXP
Tonix Pharmaceuticals Holding Corp.
AwardDirectStock Option
134.5K shares- - May 15, 2025TNXP
Tonix Pharmaceuticals Holding Corp.
PurchaseDirect4K shares at avg. $21.55$86K - Feb 25, 2025TNXP
Tonix Pharmaceuticals Holding Corp.
AwardDirectStock Option
124K shares- - Feb 25, 2025TNXP
Tonix Pharmaceuticals Holding Corp.
AwardDirectStock Option
124K shares- - Feb 5, 2025TNXP
Tonix Pharmaceuticals Holding Corp.
OtherIndirect0 shares at avg. $3.30$0.726 - Feb 5, 2025TNXP
Tonix Pharmaceuticals Holding Corp.
OtherDirect5 shares at avg. $3.38$17.508
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jun 9, 2026 | TNXP Tonix Pharmaceuticals Holding Corp. | Purchase | 5,000 | $11.79 | $58,950 | Direct |
| Mar 31, 2026 | TNXP Tonix Pharmaceuticals Holding Corp. | Purchase | 5,000 | $12.62 | $63,100 | Indirect |
| Mar 18, 2026 | TNXP Tonix Pharmaceuticals Holding Corp. | Purchase | 15,000 | $14.89 | $223,350 | Indirect |
| Feb 24, 2026 | TNXP Tonix Pharmaceuticals Holding Corp. | Award Stock Option | 134,503 | - | - | Direct |
| Feb 24, 2026 | TNXP Tonix Pharmaceuticals Holding Corp. | Award Stock Option | 134,504 | - | - | Direct |
| May 15, 2025 | TNXP Tonix Pharmaceuticals Holding Corp. | Purchase | 4,000 | $21.55 | $86,200 | Direct |
| Feb 25, 2025 | TNXP Tonix Pharmaceuticals Holding Corp. | Award Stock Option | 123,958 | - | - | Direct |
| Feb 25, 2025 | TNXP Tonix Pharmaceuticals Holding Corp. | Award Stock Option | 123,958 | - | - | Direct |
| Feb 5, 2025 | TNXP Tonix Pharmaceuticals Holding Corp. | Other | 0 | $3.30 | $1 | Indirect |
| Feb 5, 2025 | TNXP Tonix Pharmaceuticals Holding Corp. | Other | 5 | $3.38 | $18 | Direct |
1-10 of 11 transactions